Page last updated: 2024-09-02

pd 123177 and amastatin

pd 123177 has been researched along with amastatin in 2 studies

Compound Research Comparison

Studies (pd 123177)	Trials (pd 123177)	Recent Studies (post-2010) (pd 123177)	Studies (amastatin)	Trials (amastatin)	Recent Studies (post-2010) (amastatin)
142	0	2	183	0	19

Protein Interaction Comparison

Protein	Taxonomy	pd 123177 (IC50)	amastatin (IC50)
Aminopeptidase N	Sus scrofa (pig)		1.1
Angiotensin-converting enzyme	Rattus norvegicus (Norway rat)		1.1

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eijsman, L; Feenstra, M; Li, Q; Pfaffendorf, M; van Zwieten, PA	1
Li, Q; Pfaffendorf, M; van Zwieten, PA	1

Other Studies

2 other study(ies) available for pd 123177 and amastatin

Article	Year
Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein. Journal of cardiovascular pharmacology, 1997, Volume: 29, Issue:4 Topics: Aged; Aged, 80 and over; Aminopeptidases; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Anti-Bacterial Agents; Antihypertensive Agents; Biphenyl Compounds; Dose-Response Relationship, Drug; Drug Synergism; Female; Glutamyl Aminopeptidase; Humans; Imidazoles; In Vitro Techniques; Losartan; Male; Metalloendopeptidases; Methionyl Aminopeptidases; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Peptides; Protease Inhibitors; Pyridines; Saphenous Vein; Tachyphylaxis; Tetrazoles; Vasoconstrictor Agents	1997
Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries. Fundamental & clinical pharmacology, 2001, Volume: 15, Issue:2 Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Antihypertensive Agents; Biphenyl Compounds; Endothelium, Vascular; Femoral Artery; Imidazoles; In Vitro Techniques; Irbesartan; Leucine; Losartan; Male; Peptides; Protease Inhibitors; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Renal Artery; Tetrazoles; Vasoconstrictor Agents	2001

Article

Year

Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.

Journal of cardiovascular pharmacology, 1997, Volume: 29, Issue:4

Topics: Aged; Aged, 80 and over; Aminopeptidases; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Anti-Bacterial Agents; Antihypertensive Agents; Biphenyl Compounds; Dose-Response Relationship, Drug; Drug Synergism; Female; Glutamyl Aminopeptidase; Humans; Imidazoles; In Vitro Techniques; Losartan; Male; Metalloendopeptidases; Methionyl Aminopeptidases; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Peptides; Protease Inhibitors; Pyridines; Saphenous Vein; Tachyphylaxis; Tetrazoles; Vasoconstrictor Agents

1997

Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.

Fundamental & clinical pharmacology, 2001, Volume: 15, Issue:2

Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Antihypertensive Agents; Biphenyl Compounds; Endothelium, Vascular; Femoral Artery; Imidazoles; In Vitro Techniques; Irbesartan; Leucine; Losartan; Male; Peptides; Protease Inhibitors; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Renal Artery; Tetrazoles; Vasoconstrictor Agents

2001